UFP Technologies, Inc. (NASDAQ:UFPT) Shares Acquired by Geneva Capital Management LLC

Geneva Capital Management LLC lifted its stake in UFP Technologies, Inc. (NASDAQ:UFPT) by 0.3% during the 3rd quarter, HoldingsChannel.com reports. The fund owned 80,362 shares of the industrial products company’s stock after purchasing an additional 243 shares during the quarter. Geneva Capital Management LLC’s holdings in UFP Technologies were worth $25,450,000 at the end of the most recent quarter.

A number of other hedge funds have also recently made changes to their positions in the stock. Northwest Investment Counselors LLC purchased a new position in shares of UFP Technologies during the third quarter worth $32,000. EverSource Wealth Advisors LLC grew its position in UFP Technologies by 1,614.3% in the 1st quarter. EverSource Wealth Advisors LLC now owns 120 shares of the industrial products company’s stock valued at $30,000 after acquiring an additional 113 shares in the last quarter. Advisors Asset Management Inc. purchased a new stake in UFP Technologies during the first quarter worth about $35,000. Point72 Asia Singapore Pte. Ltd. purchased a new position in shares of UFP Technologies in the second quarter valued at approximately $36,000. Finally, GAMMA Investing LLC grew its holdings in shares of UFP Technologies by 77.9% in the third quarter. GAMMA Investing LLC now owns 137 shares of the industrial products company’s stock valued at $43,000 after purchasing an additional 60 shares in the last quarter. Hedge funds and other institutional investors own 87.28% of the company’s stock.

Analyst Upgrades and Downgrades

Separately, Lake Street Capital raised their price target on shares of UFP Technologies from $344.00 to $392.00 and gave the company a “buy” rating in a research report on Wednesday, July 17th.

Insiders Place Their Bets

In other UFP Technologies news, Director Cynthia L. Feldmann sold 647 shares of the stock in a transaction that occurred on Friday, November 8th. The shares were sold at an average price of $352.30, for a total value of $227,938.10. Following the transaction, the director now directly owns 4,049 shares in the company, valued at $1,426,462.70. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. In other UFP Technologies news, Director Cynthia L. Feldmann sold 647 shares of the company’s stock in a transaction on Friday, November 8th. The shares were sold at an average price of $352.30, for a total value of $227,938.10. Following the completion of the transaction, the director now owns 4,049 shares in the company, valued at $1,426,462.70. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CFO Ronald J. Lataille sold 2,392 shares of UFP Technologies stock in a transaction dated Friday, August 23rd. The stock was sold at an average price of $329.04, for a total value of $787,063.68. Following the sale, the chief financial officer now owns 38,940 shares in the company, valued at $12,812,817.60. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 23,747 shares of company stock valued at $7,799,015 in the last ninety days. Insiders own 6.17% of the company’s stock.

UFP Technologies Stock Up 0.0 %

Shares of NASDAQ:UFPT opened at $343.64 on Wednesday. UFP Technologies, Inc. has a fifty-two week low of $140.52 and a fifty-two week high of $366.41. The firm’s 50 day moving average price is $310.37 and its 200 day moving average price is $293.70. The stock has a market cap of $2.64 billion, a price-to-earnings ratio of 49.02 and a beta of 0.96. The company has a quick ratio of 1.43, a current ratio of 2.56 and a debt-to-equity ratio of 0.61.

UFP Technologies Company Profile

UFP Technologies, Inc designs and manufactures solutions for medical devices, sterile packaging, and other highly engineered custom products. The company offers protective drapes for robotic surgery, single patient use surfaces, advanced wound care, infection prevention, disposables for surgical and endoscopic procedures, packaging for medical devices, orthopedic implants, biopharma drug manufacturing, and coils for catheters; and molded components for applications in acoustic insulation, interior trim, load floors, sunshades, SUV cargo cover handles, driveshaft damping, engine and manifold covers, quarter panels, and wheel liners.